-
Taxonomy & unit
-
us-gaap: shares
-
Description
-
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
-
Summary
-
Mirati Therapeutics, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from Q1 2013 to Q3 2023.
- Mirati Therapeutics, Inc. Weighted Average Number of Shares Outstanding, Diluted for the quarter ending September 30, 2023 was 65M shares, a 15.6% increase year-over-year.
- Mirati Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 56.2M shares, a 8.38% increase from 2021.
- Mirati Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2021 was 51.9M shares, a 15.3% increase from 2020.
- Mirati Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2020 was 45M shares, a 20.1% increase from 2019.
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Growth (%)